Lumos PharmaLUMO
13F holders, Q1 2024 (March 31)36holders
3famous investors
$2.82avg. 13F price*
At the end of Q1 2024, 36 institutions reported holding Lumos Pharma Inc. (LUMO) in their 13F filings. The largest holders were Wells Fargo & Company ($1.2M), Goldman Sachs Group Inc. ($1.1M) and Vanguard Group Inc. ($688K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lumos Pharma Inc.
- CUSIP
- 55028X109
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $143K |
| Exits | 2 | $448 |
Ownership 36 holders
| Wells Fargo & Company | 0.00% | Reduce -0.4% | 415,551 | $1.2M |
| Goldman Sachs Group Inc. | 0.00% | Add +0.0% | 406,612 | $1.1M |
| Vanguard Group Inc. | 0.00% | No change | 244,082 | $688K |
| Renaissance Technologies | 0.00% | Reduce -1.6% | 218,014 | $615K |
| Acuitas Investments, LLC | 0.20% | Add +12.3% | 140,689 | $397K |
| Jefferies Financial Group Inc. | 0.01% | No change | 120,651 | $340K |
| Lion Point Capital, LP | 0.50% | No change | 90,794 | $256K |
| Blackstone Inc. | 0.00% | Reduce -75.9% | 78,624 | $222K |
| Greenwich Wealth Management LLC | 0.02% | No change | 76,341 | $215K |
| Geode Capital Management, LLC | 0.00% | No change | 47,596 | $134K |
| BlackRock Inc. | 0.00% | Reduce -5.4% | 41,104 | $116K |
| Two Sigma Investments, LP | 0.00% | Reduce -8.9% | 38,817 | $109K |
| Millennium Management | 0.00% | New | 37,579 | $106K |
| Two Sigma Advisers, LP | 0.00% | Add +12.7% | 31,900 | $90K |
| Dimensional Fund Advisors LP | 0.00% | Add +90.3% | 29,617 | $84K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -42.0% | 27,643 | $78K |
| Marquette Asset Management, LLC | 0.01% | No change | 25,760 | $73K |
| Envestnet Asset Management Inc. | 0.00% | Add +34.9% | 16,115 | $45K |
| Private Advisor Group, LLC | 0.00% | No change | 16,013 | $45K |
| Citadel Advisors | 0.00% | New | 13,286 | $37K |
| Bank of New York Mellon Corp | 0.00% | No change | 11,858 | $33K |
| Wealth Advisors of Iowa, LLC | 0.02% | No change | 11,699 | $33K |
| State Street Corp. | 0.00% | No change | 11,237 | $32K |
| Key Financial Inc | 0.01% | No change | 10,927 | $31K |
| Paladin Advisory Group, LLC | 0.01% | No change | 4,387 | $12K |
| UBS Group AG | 0.00% | Add +4944.6% | 3,733 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +71.0% | 2,691 | $8K |
| Bank of America Corp. | 0.00% | No change | 1,800 | $5K |
| West Financial Advisors, LLC | 0.00% | No change | 784 | $2K |
| Morgan Stanley | 0.00% | No change | 166 | $468 |
| Osaic Holdings, Inc. | 0.00% | Reduce -96.7% | 154 | $435 |
| Group One Trading LLC | 0.00% | No change | 150 | $423 |
| JPMorgan Chase & Co. | 0.00% | Add +7.9% | 41 | $116 |
| Global Retirement Partners, LLC | 0.00% | No change | 11 | $31 |
| Qube Research & Technologies Ltd | 0.00% | No change | 3 | $8 |
| Royal Bank of Canada | 0.00% | No change | 78 | $0 |
"% of holder's portfolio" is LUMO's weight in each manager's 13F, not the share of Lumos Pharma Inc. the manager owns.